References
- Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr. 2003;22(5):445–52.
- Parrish CR, DiBaise JK. Managing the adult patient with short bowel syndrome. Gastroenterol Hepatol. 2017;13(10):600–8.
- Winkler MF, Hagan E, Wetle T, Smith C, Maillet JS, Touger-Decker R. An exploration of quality of life and the experience of living with home parenteral nutrition. J Parenter Enteral Nutr. 2010;34(4):395–407.
- Gondal B, Trivedi MC. An overview of ostomies and the high-output ostomy. Hosp Med Clin. 2013;2(4):e542–51.
- Billiauws L, Bataille J, Boehm V, Corcos O, Joly F. Teduglutide for treatment of adult patients with short bowel syndrome. Expert Opin Biol Ther. 2017;17(5):623–32.
- Jeppesen PB, Game SM, Seidner DL, Lee HM, Olivier C. Factors associated with response to teduglutide in patients with short bowel syndrome and intestinal failure. Gastroenterology. 2018;154:874–85.
- Kim ES, Keam SJ. Teduglutide: a review in short bowel syndrome. Drugs 2017;77(3):345–52.
- Klek S, Kunecki M, Sobocki J, Matysiak K, Karwowska K, Urbanowicz K. The Polish intestinal failure centres’ consensus on the use of teduglutide for the treatment of short bowel syndrome. Nutrition 2017;38:28–33.
- Lexi-Comp, Inc. (Lexi-Drugs). Lexi-Comp, Inc.; June 4, 2018.